Skip to main content

Animations

MJFF Publications

6081 - 6090 of 6516 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41598-025-11979-8
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Structural insights into allosteric inhibition of HRI kinase by heme binding via HDX-MS
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20253072
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00967-4
    Citation Count: 5
  • Summary Details
    OPEN
    Title: [125I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer's Disease Hippocampus‐Subiculum and Evaluation of Drug Effects
    Journal Name: Synapse
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/syn.70024
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Deep Learning for Fluorescence Lifetime Predictions Enables High-Throughput In Vivo Imaging
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1021/jacs.5c03749
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Benchmarking methods for mapping functional connectivity in the brain
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-025-02704-4
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Human pegivirus alters brain and blood immune and transcriptomic profiles of patients with Parkinson’s disease
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.189988
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Prevalence and associations of self‐reported sleep problems in a large sample of patients with Parkinson's disease
    Journal Name: Journal of Sleep Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/jsr.14453
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01041-9
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Derailed degradation: LRRK2-dependent exocytosis in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2515758122
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.